ЛИТЕРАТУРА

1. Олисова О.Ю. Совершенствование диагностики и лечения доброкачественной лимфоплазии кожи / О.Ю. Олисова, Е.М. Анпилогова, Х.С. Косумова, Е.Е. Никулина // Российский журнал кожных и венерических болезней. 2021. Т. 24. № 5. С. 429–442. https://doi.org/10.17816/dv96711

2. Самцов А.В. Клинические, гистологические и иммуногистохимические особенности лимфом кожи на современном этапе / А.В. Самцов, И.Э. Белоусова // Вестник дерматологии и венерологии. 2006. № 1. С. 3–6.

3. Allison R. Photodynamic Therapy (PDT): PDT Mechanisms / R. Allison, K. Moghissi // Clin Endosc. 2013. Vol. 46. P. 24–29. doi: 10.5946/ce.2013.46.1.24.

4. Bouchy C. Hyperplasie lymphoïde chronique (pseudolymphome) sur l'encre rouge de tatouage [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo] / C. Gardair Bouchy, R. Kerdraon, N. Kluger, P. Armingaud, A. Wakosa, E. Estève // Ann Pathol. 2013. Vol. 33. N. 4. P. 273–277. French. doi: 10.1016/j.annpat.2013.04.005.

5. Bouloc A. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas / A. Bouloc, M. Delfau-Larue, B. Lenormand, F. Meunier, J. Wechsler, et al. // Arch Dermatol. 1999. Vol. 135. N. 2. P. 168–172. doi: 10.1001/archderm.135.2.168.

6. Bowman E. Developmental switches in chemokine response profiles during B-cell differentiation and maturation / E. Bowman, J. Campbell, D. Soler et al. // J. Exp. Med. 2000. Vol. 191. P. 1303–1318.

7. Brouwer E. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders / E. Brouwer, J. Tervaert, G. Horst, M. Huitema, M. van der Giessen, P. Limburg, C. Kallenberg // Clin Exp Immunol. 1991. Vol. 83. N. 3. P. 379–386.

8. Burg G. Cutaneous pseudolymphomas. In: Burg G, Kempf W, editors. Cutaneous lymphomas / G. Burg, W. Kempf, D. Kazakov. London, UK: Taylor & Francis; 2005.

9. Burg G. Cutaneous lymphomas, pseudolymphomas, and related disorders / G. Burg, O. Braun-Falco. Berlin: Springer Verlag, 1983.

10. Cadera E. NF-kappaB activity marks cells engaged in receptor editing / E. Cadera, F. Wan, R. Amin, H. Nolla, M. Lenardo, M. Schlissel // J. Exp. Med. 2009. Vol. 206. P. 1803–1816.

11. Cassisa A. Primary Cutaneous Follicle Center Lymphoma Clear Cell Variant: Expanding the Spectrum of Cutaneous Clear Cell Neoplasms / A. Cassisa, F. Colpan, R. Rinaldi, L. Cima // Am J. Dermatopathol. 2018. Vol. 40. N. 11. P. 849–853. doi: 10.1097/DAD.0000000000001195.

12. Cerroni L. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas / L. Cerroni, H. Kerl // Semin Cutan Med Surg. 1999. Vol. 8. N. 1. P. 64–70. doi: 10.1016/s1085-5629(99)80010-8.

13. Cesinaro A. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases / A. Cesinaro, S. Lonardi, F. Facchetti // Am J. Surg Pathol. 2013. Vol. 37. P. 66–73.

14. Charli-Joseph Y. Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma? / Y. Charli-Joseph, M. Gatica-Torres, L. Pincus // Indian J. Dermatol. 2016. Vol. 61. N. 4. P. 351–374. doi: 10.4103/0019-5154.185698.

15. Choi E. Corticosteroid phobia: a questionnaire study using TOPICOP score / E. Choi, N. Chandran, C. Tan // Singapore Med J. 2020. Vol. 61. N. 3. P. 149–153. doi: 10.11622/smedj.2019110.

16. Choi M. Clinical and histopathological characteristics of cutaneous lymphoid hyperplasia: a comparative study according to causative factors / M. Choi, K. Lee, D. Lim, C. Won, S. Chang, M. Lee, et al. // J. Clin Med. 2020. Vol. 9. N. 4. P. 1217. doi: 10.3390/jcm9041217.

17. Choi M. A case of cutaneous lymphoid hyperplasia after hyaluronic acid filler injection and fat grafting / M. Choi, C. Won, S. Chang, M. Lee, J. Choi, W. Lee // Australas J Dermatol. 2019. Vol. 60. N. 1. e71–73. doi: 10.1111/ajd.12907.

18. Comfere N. Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders / N. Comfere, U. Sundram, M. Hurley, B. Swick // J Cutan Pathol. 2018. Vol. 45. N. 1. P. 39–47. doi: 10.1111/cup.13072.

19. Dadban, A. Cutaneous lymphoid hyperplasia on a preexistent melanocytic nevus / A. Dadban, F. Truchetet // Dermatology. 2008. Vol. 217. N. 3. P. 199–200. doi: 10.1159/000141650.

20. Dionyssopoulos A. T- and B-cutaneous pseudolymphomas treated by surgical excision and immediate reconstruction / A. Dionyssopoulos, I. Mandekou-Lefaki, F. Delli, D. Kourtis, A. Nikolis, et al. // Dermatol Surg. 2006. Vol. 32. P. 1526–1529.

21. Dodiuk-Gad R. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist / R. Dodiuk-Gad, S. Ish-Shalom, S. Shear // Int J. Dermatol. 2015. Vol. 54. N. 6. P. 723–729. doi: 10.1111/ijd.12642.

22. Ebrahim A. Hematologic malignancies: newer strategies to counter the BCL-2 protein / A. Ebrahim, H. Sabbagh, A. Liddane, A. Raufi, M. Kandouz, A. Al-Katib // J Cancer Res Clin Oncol. 2016. Vol. 142. N. 9. P. 2013–2022. doi: 10.1007/s00432-016-2144-1.

23. Egawa G. Role of Lymphoid Structure in Skin Immunity / G. Egawa, K. Kabashima // Curr Top Microbiol Immunol. 2020. Vol. 426. P. 65–82. doi: 10.1007/82_2020_206.

24. Fan L. Photodynamic therapy for rosacea in Chinese patients / L. Fan, R. Yin, T. Lan, M. Hamblin // Photodiagnosis Photodyn Ther. 2018. Vol. 24. P. 82–87. doi: 10.1016/j.pdpdt.2018.08.005.

25. Fernandez-Flores A. The role of IgG4 in cutaneous pathology / A. Fernandez-Flores // Rom J Morphol Embryol. 2012. Vol. 53. N. 2. P. 221–231.

26. Fernandez-Faith E. Cutaneous sarcoidosis: differential diagnosis / E. Fernandez-Faith, J. McDonnell // Clin Dermatol. 2007. Vol. 25. N. 3. P. 276–287. doi: 10.1016/j.clindermatol.2007.03.004.

27. Gilliam A. Cutaneous lymphoid hyperplasias / A. Gilliam, G. Wood // Semin Cutan Med Surg. 2000. Vol. 19. N. 2. P. 133–141. doi: 10.1016/s1085-5629(00)80011-5.

28. Hardin J. Light chain restriction confined to lower portions of cutaneous lymphocytic proliferations: a potential diagnostic pitfall / J. Hardin, B. Barrows, J. Duff, et al // J Cutan Pathol. 2014. Vol. 41. N. 12. P. 978–980.

29. Kempf W. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions / W. Kempf, D. Kazakov, C. Mitteldorf // Am J. Dermatopathol. 2014. Vol. 36. N. 3. P. 197–208. doi: 10.1097/DAD.0b013e318289b20e.

30. Kempf W. Pathologic Diagnosis of Cutaneous Lymphomas / W. Kempf, C. Mitteldorf // Dermatol Clin. 2015. Vol. 33. N. 4. P. 655–681. doi: 10.1016/j.det.2015.05.002.

31. Kempf W. Cutaneous lymphomas-An update 2019 / W. Kempf, A. Zimmermann, C. Mitteldorf // Hematol Oncol. 2019. Vol. 37. P. 43–47. doi: 10.1002/hon.2584.

32. Khelifa E. Cutaneous pseudolymphomas after leech therapy / E. Khelifa, G. Kaya, E. Laffitte // J. Dermatol. 2013. Vol. 40. N. 8. P. 674–675. doi: 10.1111/1346-8138.12198.

33. Kimura Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma / Y. Kimura, K. Harada, Y. Nakanuma // Hum. Pathol. 2012. Vol. 43. P. 2149–2156.

34. Kluger N. Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients / N. Kluger, C. Vermeulen, P. Moguelet, H. Cotten, M. Koeb, B. Balme, T. Fusade // J Eur Acad Dermatol Venereol. 2010. Vol. 24. N. 2. P. 208–213. doi: 10.1111/j.1468-3083.2009.03305.x.

35. Koh W. Cutaneous pseudolymphoma occurring after traumatic implantation of a foreign red pigment / W. Koh, Y. Tay, M. Koh, C. Sim // Singapore Med J. 2013. Vol. 54. N. 5. P. 100–101. doi: 10.11622/smedj.2013063.

36. Kokovic I. Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas / I. Kokovic, B. Jezersek Novakovic, S. Novakovic // Int J Oncol. 2015. Vol. 46. N. 3. P. 953–62. doi: 10.3892/ijo.2014.2790.

37. Koneczny I. Update on IgG4-mediated autoimmune diseases: New insights and new family members / I. Koneczny // Autoimmun Rev. 2020. Vol. 19. N. 10. P. 102646. doi: 10.1016/j.autrev.2020.102646.

38. Kuflik A. Lymphocytoma cutis: a series of five patients successfully treated with cryosurgery / A. Kuflik, R. Schwartz // J. Am Acad Dermatol. 1992. Vol. 26. P. 449–452.

39. Kulow B. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma / B. Kulow, H. Cualing, P. Steele, J. VanHorn, J. Breneman, D. Mutasim, et al // J Cutan Med Surg. 2002. Vol. 6. N. 6. P. 519–528. doi: 10.1007/s10227-001-0133-7.

40. Langerak A. EuroClonality / BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations / P. Groenen, M. Bruggemann et al. // Leukemia. 2012. Vol. 26. P. 2159–2171.

41. Lanzillotta, M. Advances in the diagnosis and management of IgG4 related disease / M. Lanzillotta, G. Mancuso, E. Della-Torre // BMJ. 2020. Vol. 369. e1067. doi: 10.1136/bmj.m1067.

42. LeBoit P. Cutaneous lymphocytic infiltrates / P. LeBoit // Am J. Dermatopathol. 2005. Vol. 27. P. 182–184.

43. Lever W. Histopathology of the skin. 4th ed. / W. Lever. London and Philadelphia, 1967. P. 736–767.

44. Olisova O. Yu. Efficacy of chlorine photodynamic therapy in cutaneous lymphoid hyperplasia / O. Yu. Olisova, E.M. Anpilogova // Dermatol Ther. 2020. Vol. 33. N. 6. e13938. doi: 10.1111/dth.13938.

45. Olsen T. Angiolymphoid hyperplasia with eosinophilia: a clinicopathologic study of 116 patients / T. Olsen, E. Helwig // J. Am Acad Dermatol. 1985. Vol. 12. P. 781–796.

46. O'Neill J. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report / J. O’Neill, S. Fien, N. Zeitouni // J Drugs Dermatol. 2010. Vol. 9. N. 6. P. 688–689.

47. Ono S. Proposal of inducible skin-associated lymphoid tissue (iSALT) / S. Ono, K. Kabashima // Exp Dermatol. 2015. Vol. 24. N. 8. P. 630–1. doi: 10.1111/exd.12716.

48. Ortonne N. Granuloma faciale: a clinicopathologic study of 66 patients / N. Ortonne, J. Wechsler, M. Bagot, E. Grosshans, B. Cribier // J. Am Acad Dermatol. 2005. Vol. 53. P. 1002–1009.

49. Poopak B. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders / B. Poopak, A. Valeshabad, F. Elahi, H. Rezvani, G. Khosravipour, M. Jahangirpour et al // Indian J Hematol Blood Transfus. 2015. Vol. 31. N. 1. P. 38–45. doi: 10.1007/s12288-014-0387-z.

50. Qia G. Is the step-up therapy of topical 5- aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart? / G. Qian, S. Wang, D. Deng, G. Yang // Dermatologic therapy. 2014. Vol. 27. N. 2. P. 83–88.

51. Radic M. Tracking and trapping somatic mutations in Ig genes / M. Radic // J. Immunol. 2008. Vol. 180. P. 5763–5764.

52. Rezk M. Cutaneous pseudolymphomas: inflammatory reactive proliferations / M. Rezk, A. Hussein // Expert Rev Hematol. 2013. Vol. 6. N. 6. P. 713–733. doi: 10.1586/17474086.2013.845000.

53. Rice J. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review / J. Rice, A. White, L. Scarpati, G. Wan, W. Nelson // Clin Ther. 2017. Vol. 39. N. 11. P. 2216–2229. doi: 10.1016/j.clinthera.2017.09.011.

54. Rijlaarsdam J. Cutaneous immunocytomas: A clinicopathologic study of 26 cases / J. Rijlaarsdam, S. Van der Putte, E. Berti et al // Histopathology. 1993. Vol. 23. P. 117–125.

55. Rijlaarsdam U. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects / U. Rijlaarsdam, V. Bakels, J. van Oostveen, R. Gordijn, M. Geerts, C. Meijer, R. Willemze // J. Invest Dermatol. 1992. Vol. 99. N. 6. P. 749–754. doi: 10.1111/1523-1747.ep12614479.

56. Ritter J. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement / J. Ritter, M. Wick, P. Adesokan, J. Fitzgibbon, X. Zhu, P. Humphrey // Am J. Clin Pathol. 1997. Vol. 108. N. 1. P. 60–68.